ES2602620A1 - In vitro method for predicting and/or forecasting the compatibility of biomaterials in a subject (Machine-translation by Google Translate, not legally binding) - Google Patents

In vitro method for predicting and/or forecasting the compatibility of biomaterials in a subject (Machine-translation by Google Translate, not legally binding) Download PDF

Info

Publication number
ES2602620A1
ES2602620A1 ES201631682A ES201631682A ES2602620A1 ES 2602620 A1 ES2602620 A1 ES 2602620A1 ES 201631682 A ES201631682 A ES 201631682A ES 201631682 A ES201631682 A ES 201631682A ES 2602620 A1 ES2602620 A1 ES 2602620A1
Authority
ES
Spain
Prior art keywords
predicting
compatibility
subject
biomaterials
translation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201631682A
Other languages
Spanish (es)
Other versions
ES2602620B1 (en
Inventor
Julio José Suay Antón
Ana María SANCHEZ PÉREZ
Isabel Goñi Echave
Mariló GURRUCHAGA TORRECILLA
Félix ELORTZA BASTERRIKA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asoc Centro De Investig Coop En Biociencias - Cic Biogune
Euskal Herriko Unibertsitatea
Universitat Jaume I de Castello
Centro de Investigacion Cooperativa en Biociencias
Original Assignee
Asoc Centro De Investig Coop En Biociencias - Cic Biogune
Euskal Herriko Unibertsitatea
Universitat Jaume I de Castello
Centro de Investigacion Cooperativa en Biociencias
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asoc Centro De Investig Coop En Biociencias - Cic Biogune, Euskal Herriko Unibertsitatea, Universitat Jaume I de Castello, Centro de Investigacion Cooperativa en Biociencias filed Critical Asoc Centro De Investig Coop En Biociencias - Cic Biogune
Priority to ES201631682A priority Critical patent/ES2602620B1/en
Publication of ES2602620A1 publication Critical patent/ES2602620A1/en
Application granted granted Critical
Priority to PCT/ES2017/070825 priority patent/WO2018115553A1/en
Publication of ES2602620B1 publication Critical patent/ES2602620B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

In vitro method to predict and/or predict the compatibility of biomaterials in a subject. The present invention relates to a set of markers, preferably proteins, all related to the pathway of the complement activation system, which are particularly useful for predicting and/or predicting the in vitro compatibility of a biomaterial, such as, for example, joint prostheses, dental prostheses, valves, stens, etc., in your subject. Additionally, the present invention comprises an in vitro method for predicting and/or predicting the compatibility of said materials by determining the peptide profile described in the invention, as well as a kit and/or device for carrying out said method. (Machine-translation by Google Translate, not legally binding)
ES201631682A 2016-12-23 2016-12-23 IN VITRO METHOD FOR PREDICTING AND / OR FORECASTING THE COMPATIBILITY OF BIOMATERIALS IN A SUBJECT Expired - Fee Related ES2602620B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ES201631682A ES2602620B1 (en) 2016-12-23 2016-12-23 IN VITRO METHOD FOR PREDICTING AND / OR FORECASTING THE COMPATIBILITY OF BIOMATERIALS IN A SUBJECT
PCT/ES2017/070825 WO2018115553A1 (en) 2016-12-23 2017-12-18 In vitro method for predicting and/or forecasting the compatibility of biomaterials in a patient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201631682A ES2602620B1 (en) 2016-12-23 2016-12-23 IN VITRO METHOD FOR PREDICTING AND / OR FORECASTING THE COMPATIBILITY OF BIOMATERIALS IN A SUBJECT

Publications (2)

Publication Number Publication Date
ES2602620A1 true ES2602620A1 (en) 2017-02-21
ES2602620B1 ES2602620B1 (en) 2017-12-18

Family

ID=58022351

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201631682A Expired - Fee Related ES2602620B1 (en) 2016-12-23 2016-12-23 IN VITRO METHOD FOR PREDICTING AND / OR FORECASTING THE COMPATIBILITY OF BIOMATERIALS IN A SUBJECT

Country Status (2)

Country Link
ES (1) ES2602620B1 (en)
WO (1) WO2018115553A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022234175A1 (en) * 2021-05-06 2022-11-10 Universitat Jaume I In vitro method for predicting and/or prognosing the ability of a biomaterial to induce tissue regeneration

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040241690A1 (en) * 2001-08-03 2004-12-02 Takayuki Souka Method of evaluating biocompatibility
US20050170445A1 (en) * 2004-01-07 2005-08-04 Duke University Methods of establishing profiles for use in evaluating wound healing and biocompatibility of implant materials and microarrays useful therefor
US20110135606A1 (en) * 2006-01-18 2011-06-09 Wick, Immunologische Diagnostik U. Beratung Kg Test systems for the analysis of polypeptides and cells adhering to silicones
ES2536310T3 (en) * 2010-04-27 2015-05-22 Fundació Hospital Universitari Vall D' Hebron - Institut De Recerca Method of detection of susceptibility to develop adverse side effects related to bioimplants

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040241690A1 (en) * 2001-08-03 2004-12-02 Takayuki Souka Method of evaluating biocompatibility
US20050170445A1 (en) * 2004-01-07 2005-08-04 Duke University Methods of establishing profiles for use in evaluating wound healing and biocompatibility of implant materials and microarrays useful therefor
US20110135606A1 (en) * 2006-01-18 2011-06-09 Wick, Immunologische Diagnostik U. Beratung Kg Test systems for the analysis of polypeptides and cells adhering to silicones
ES2536310T3 (en) * 2010-04-27 2015-05-22 Fundació Hospital Universitari Vall D' Hebron - Institut De Recerca Method of detection of susceptibility to develop adverse side effects related to bioimplants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MULLER R et al. Chemiluminescence-based detection and comparison of protein amounts adsorbed on differently modified silica surfaces.Analytical Biochemistry, 20061215 ELSEVIER, AMSTERDAM, NL 15/12/2006 VOL: 359 No: 2 Pags: 194 - 202 ISSN 0003-2697 Doi: doi:10.1016/j.ab.2006.09.032. Páginas 195-198. *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022234175A1 (en) * 2021-05-06 2022-11-10 Universitat Jaume I In vitro method for predicting and/or prognosing the ability of a biomaterial to induce tissue regeneration
ES2927794A1 (en) * 2021-05-06 2022-11-10 Univ Jaume I IN VITRO METHOD TO PREDICT AND/OR FORECAST THE ABILITY TO INDUCE TISSUE REGENERATION BY A BIOMATERIAL (Machine-translation by Google Translate, not legally binding)

Also Published As

Publication number Publication date
ES2602620B1 (en) 2017-12-18
WO2018115553A1 (en) 2018-06-28

Similar Documents

Publication Publication Date Title
AR123115A1 (en) COMPOSITIONS AND METHODS FOR THE SELECTIVE DEGRADATION OF PROTEINS
CO2018011364A2 (en) Anti-il-33 antibodies, compositions, methods and uses thereof
MA41669A1 (en) Antibodies binding to tau
CO2018005436A2 (en) Antibodies and antibody fragments for site-specific conjugation
CO2017007665A2 (en) Icos binding proteins
BR112019010943A2 (en) Cancer treatment methods comprising tigit binding agents
ECSP18023386A (en) STROMAL THYMIC LYMPHOPOYETIN (TSLP) BINDING MOLECULES AND METHODS OF USE OF THE MOLECULES
IL282981A (en) Compositions, methods and systems for protein corona analysis and uses thereof
CR20160206A (en) Compositions and methods for antibodies that target C5 complement protein
CR20180013A (en) ANTI-TAU ANTIBODIES AND METHODS OF USE.
EP4242304A3 (en) Methods and reagents for analyzing protein-protein interfaces
CL2019002605A1 (en) Formulations containing pd-1 binding proteins and methods of manufacturing the same.
MA41670A1 (en) Antibodies binding to tau
EA201792245A1 (en) BIOCONJUGATES AND THEIR APPLICATIONS
AU2018262331A8 (en) Methods for trapping and barcoding discrete biological units in hydrogel
BR112018015965A2 (en) Helicobacter pylori determination method
MX2018015237A (en) A method for identifying the extent of aging in an asphalt.
CL2017002705A1 (en) Antibodies that target bone morphogenic protein 9 (bmp9) and the methods to which they refer
BR112018071107A2 (en) compositions and methods for detecting host cell proteins
AU2018256348A1 (en) A platform for T lymphocyte genome engineering and in vivo high-throughput screening thereof
ZA202102546B (en) Methods for identifying free thiols in proteins
MX2021000899A (en) Compositions and methods for determining endometrial cancer prognosis.
EP3616802A4 (en) Scale composition determination system, scale composition determination method, and program
ES2602620A1 (en) In vitro method for predicting and/or forecasting the compatibility of biomaterials in a subject (Machine-translation by Google Translate, not legally binding)
BR112017008011A2 (en) proximity-based methods for selection of liaison partners

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2602620

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20171218

FD2A Announcement of lapse in spain

Effective date: 20240326